The Trump administration is working on an executive order that would lower prices on all branded drugs sold to Medicare Part B and Part D, according to an exclusive Reuters report.
Six things to know:
1. The executive order would be much broader than a previous proposal discussed to lower prices of physician-administered, or Part B drugs, according to Reuters. That proposal sought to lower drug prices by tying them to the price other developed countries pay.
2. The administration is now looking at ways to lower prices of Part D drugs as well, which encompass prescription drugs patients take at home.
3. President Donald Trump also is considering expanding price controls to the Defense Department, which runs the Tricare health insurance plan, and the Department of Veterans Affairs, anonymous sources told Reuters.
4. The order could come in the next few weeks, the sources told Reuters.
5. The White House could delay the order if the Senate bill to lower drug costs unveiled this week by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore, seems to be gaining bipartisan support, the sources said.
6. The White House and HHS declined Reuters' request for comment on the proposal.
Access the full report here.